Van Weyenbergh J, Lipinski P, Abadie A, Chabas D, Blank U, Liblau R, Wietzerbin J
Unité 365, Institut National de la Santé et de la Recherche Médicale, Institut Curie, Paris, France.
J Immunol. 1998 Aug 1;161(3):1568-74.
Monocyte-macrophage activation by IFN-gamma is characterized by a pronounced increase of high affinity Fc receptors for IgG (Fc gamma RI), capable of triggering respiratory burst, phagocytosis, Ab-dependent cytotoxicity, and release of proinflammatory cytokines. In view of the antagonism of IFN-beta on IFN-gamma action, of interest in the chronic inflammatory disorder multiple sclerosis, we examined the possible effect of IFN-beta on IFN-gamma induction of Fc gamma RI gene expression. We found that IFN-beta significantly down-regulated IFN-gamma-induced Fc gamma RI surface expression in peripheral blood monocytes from healthy donors, in a dose- and time-dependent manner. This down-regulation of Fc gamma RI surface levels did not correspond to a decrease in Fc gamma RI mRNA, suggesting a posttranscriptional effect of IFN-beta. Down-regulation of Fc gamma RI surface expression correlated with diminished cellular signaling through Fc gamma RI, since the IFN-gamma-induced increase in Fc gamma receptor-triggered respiratory burst was nearly completely abrogated by simultaneous addition of IFN-beta. Finally, the same antagonism between both IFNs on Fc gamma RI surface expression was observed in peripheral blood monocytes derived from multiple sclerosis patients; inhibition by IFN-beta was even increased (82+/-11%), as compared with healthy controls (67+/-4%). These results may partially help explain the beneficial effect of IFN-beta in multiple sclerosis.
γ干扰素激活单核细胞-巨噬细胞的特征是,其针对IgG的高亲和力Fc受体(FcγRI)显著增加,该受体能够引发呼吸爆发、吞噬作用、抗体依赖性细胞毒性以及促炎细胞因子的释放。鉴于β干扰素对γ干扰素作用的拮抗作用,考虑到其在慢性炎症性疾病多发性硬化症中的作用,我们研究了β干扰素对γ干扰素诱导FcγRI基因表达的可能影响。我们发现,β干扰素以剂量和时间依赖性方式显著下调健康供体外周血单核细胞中γ干扰素诱导的FcγRI表面表达。FcγRI表面水平的这种下调与FcγRI mRNA的减少并不对应,这表明β干扰素具有转录后效应。FcγRI表面表达的下调与通过FcγRI的细胞信号传导减弱相关,因为同时添加β干扰素几乎完全消除了γ干扰素诱导的Fcγ受体触发的呼吸爆发增加。最后,在多发性硬化症患者来源的外周血单核细胞中也观察到了两种干扰素对FcγRI表面表达的相同拮抗作用;与健康对照(67±4%)相比,β干扰素的抑制作用甚至增强(82±11%)。这些结果可能部分有助于解释β干扰素在多发性硬化症中的有益作用。